HedgePath Pharmaceuticals Announces Additional Expanded Patent Coverage

Author's Avatar
May 21, 2018
Article's Main Image

HPPI's patent portfolio expands again with claims covering treatment of any non-cancerous proliferation disorders with itraconazole, the active ingredient in HPPI's current and anticipated future product candidates

PR Newswire